BRIEF published on 06/18/2026 at 07:35, 6 days 2 hours ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
BRIEF published on 06/18/2026 at 07:35, 6 days 2 hours ago ABIONYX Pharma réussit son augmentation de capital Augmentation De Capital Essai Clinique Financement Obligataire Sepsis Fenja Capital
BRIEF published on 06/18/2026 at 07:35, 6 days 2 hours ago ABIONYX Pharma finalise avec succès un financement de 33 millions d'euros. Augmentation De Capital ABIONYX Pharma Fenja Capital Financement Par Obligations Recherche Sur La Septicémie
BRIEF published on 06/18/2026 at 07:35, 6 days 2 hours ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
PRESS RELEASE published on 06/18/2026 at 07:30, 6 days 2 hours ago Informations privilégiées / Autres communiqués ABIONYX Pharma annonce le succès de son financement de 33 M€ pour renforcer son développement clinique et sa trésorerie. Les actionnaires historiques soutiennent l'opération Financement Trésorerie Développement Clinique Actionnaires Historiques ABIONYX Pharma
PRESS RELEASE published on 06/18/2026 at 07:30, 6 days 2 hours ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
BRIEF published on 05/28/2026 at 19:11, 26 days 14 hours ago ABIONYX Pharma annonce un premier trimestre stable et un financement solide pour sa croissance future. Augmentation De Capital Essais Cliniques Stabilité Financière ABIONYX Pharma Recettes 2026
BRIEF published on 05/28/2026 at 19:11, 26 days 14 hours ago ABIONYX Pharma Reports Stable First Quarter and Robust Financing for Future Growth Clinical Trials Capital Increase Financial Stability ABIONYX Pharma Revenue 2026
BRIEF published on 05/28/2026 at 19:11, 26 days 14 hours ago ABIONYX Pharma : Bilan du premier trimestre 2026 Chiffre D'affaires Financement Trésorerie Sepsis Thérapies Innovantes
BRIEF published on 05/28/2026 at 19:11, 26 days 14 hours ago ABIONYX Pharma: Review of the first quarter of 2026 Revenue Treasury Funding Innovative Therapies Sepsis
Published on 06/24/2026 at 03:15, 6 hours 47 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 10 hours 2 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 10 hours 17 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 10 hours 42 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 10 hours 47 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 09:46, 16 minutes ago Elring extends Aftermarket portfolio to include solutions for commercial vehicles from Asian OEMs
Published on 06/24/2026 at 09:37, 25 minutes ago KNDS ANNOUNCES INTENTION TO PROCEED WITH AN IPO TO SUPPORT ITS LONG-TERM GROWTH STRATEGY
Published on 06/24/2026 at 09:34, 27 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 06/24/2026 at 09:30, 32 minutes ago CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”
Published on 06/23/2026 at 19:47, 14 hours 14 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 14 hours 14 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 14 hours 52 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 14 hours 52 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
